These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29191624)

  • 21. The role of daily dialysis in the control of hyperphosphatemia.
    Achinger SG; Ayus JC
    Kidney Int Suppl; 2005 Jun; (95):S28-32. PubMed ID: 15882310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphate salivary secretion in hemodialysis patients: implications for the treatment of hyperphosphatemia.
    Savica V; Calò LA; Caldarera R; Cavaleri A; Granata A; Santoro D; Savica R; Muraca U; Mallamace A; Bellinghieri G
    Nephron Physiol; 2007; 105(3):p52-5. PubMed ID: 17220638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis.
    O'Lone E; Connors M; Masson P; Wu S; Kelly PJ; Gillespie D; Parker D; Whiteley W; Strippoli GF; Palmer SC; Craig JC; Webster AC
    Am J Kidney Dis; 2016 Jun; 67(6):925-35. PubMed ID: 26919914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of educational or behavioral interventions on adherence to phosphate control in adults receiving hemodialysis: a systematic review.
    Milazi M; Bonner A; Douglas C
    JBI Database System Rev Implement Rep; 2017 Apr; 15(4):971-1010. PubMed ID: 28398983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?
    Morton AR; Murphy S; Hirsch D; Leblanc M; Barré P; Lok C; Hercz G; Hodsman A; Reslerova M; Levin A
    Hemodial Int; 2010 Apr; 14(2):200-10. PubMed ID: 20337745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary glands: a new player in phosphorus metabolism.
    Savica V; Calò LA; Santoro D; Monardo P; Santoro G; Muraca U; Davis PA; Bellinghieri G
    J Ren Nutr; 2011 Jan; 21(1):39-42. PubMed ID: 21195917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are calcium-based phosphate binders ever preferable in dialysis patients?
    Jain N; Reilly RF
    Semin Dial; 2014; 27(3):269-72. PubMed ID: 24620781
    [No Abstract]   [Full Text] [Related]  

  • 28. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.
    Reddy V; Symes F; Sethi N; Scally AJ; Scott J; Mumtaz R; Stoves J
    J Ren Nutr; 2009 Jul; 19(4):314-20. PubMed ID: 19539185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifications to bicarbonate conductivity: A way to increase phosphate removal during hemodialysis? Proof of concept.
    Bertocchio JP; Mohajer M; Gaha K; Ramont L; Maheut H; Rieu P
    Hemodial Int; 2016 Oct; 20(4):601-609. PubMed ID: 27060343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphate control in end-stage renal disease: barriers and opportunities.
    Waheed AA; Pedraza F; Lenz O; Isakova T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2961-8. PubMed ID: 23901051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
    Zwiech R; Dryja P; Łacina D; Króliczak V; Chrul S; Kacprzyk F
    Wiad Lek; 2011; 64(1):9-14. PubMed ID: 21812357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
    Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphate: a stealthier killer than previously thought?
    Gonzalez-Parra E; Tuñón J; Egido J; Ortiz A
    Cardiovasc Pathol; 2012; 21(5):372-81. PubMed ID: 22425627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotinic acid and nicotinamide: a review of their use for hyperphosphatemia in dialysis patients.
    Rennick A; Kalakeche R; Seel L; Shepler B
    Pharmacotherapy; 2013 Jun; 33(6):683-90. PubMed ID: 23526664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphate levels and blood pressure in incident hemodialysis patients: a longitudinal study.
    Huang CX; Plantinga LC; Fink NE; Melamed ML; Coresh J; Powe NR
    Adv Chronic Kidney Dis; 2008 Jul; 15(3):321-31. PubMed ID: 18565483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphate homeostasis and the renal-gastrointestinal axis.
    Marks J; Debnam ES; Unwin RJ
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F285-96. PubMed ID: 20534868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
    Patel L; Bernard LM; Elder GJ
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia.
    Shigematsu T;
    Clin Nephrol; 2008 Nov; 70(5):404-10. PubMed ID: 19000540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial.
    Walsh M; Manns BJ; Klarenbach S; Tonelli M; Hemmelgarn B; Culleton B
    Hemodial Int; 2010 Apr; 14(2):174-81. PubMed ID: 20041960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis.
    Sampaio MS; Ruzany F; Dorigo DM; Suassuna JH
    Am J Nephrol; 2012; 36(2):121-6. PubMed ID: 22776782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.